1Delialioglu N, Aslan G, Ozturk C, et al. Inducible clindamycin resistance in staphylococci isolated from clinical samples [J]. Jpn J Infect Dis, 2005, 58(2): 104-106.
2Acikgoz ZC, Almayanlar E, Gamberzade S, et al. Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital [J]. Antimicrob Agents Chemother, 2004, 48(4): 1410-1412.
5Lina G, Quaglia A, Reverdy ME, et al. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci[J]. Antimicrob Agents Chemother, 1999, 43(5) : 1062-1066.
7Biedenbach DJ, Stephen JM, Jones RN. Antimicrobial susceptibility profile among beta-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program-North America, 2001 [J]. Diagn Microbiol Infect Dis, 2003,46(4) : 291- 294.
8Canu A, Malbruny B, Coquemont M, et al. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae [J]. Antimicrob Agents Chemother, 2002, 46(1) : 125-131.
9Tait-Kamradt A, Davies T, Cronan M, et al. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage [J]. Antimicrob Agents Chemother, 2000, 44(8): 2118-2125.
10Pihlajamaki M, Kataja J, Seppala H, et al. Ribosomal mutations in Streptococcus pneumoniae clinical isolates [J]. Antimicrob Agents Chemother, 2002, 46(3) : 654-658.
二级参考文献19
1National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing.Pennsylvania:NCCLS,2002.M100-S12.
2Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms.Clin Microbiol Infect,1996,2 Suppl 1:S46.
3Morosini MI,Canton R,Loza E,et al.In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.Antimicrob Agents Chemother,2001,45:2427-2431.
4Sutcliffe J,Grebe T,Tait-Kamradt A,et al.Detection of erythromycin-resistant determinants by PCR.Antimicrob Agents Chemother,1996,40:2562-2566.
5Kataja J,Huovinen P,Skurnik M,et al.Erythromycin resistance genes in group A streptococci in Finland.The Finnish Study Group for Antimicrobial Resistance.Antimicrob Agents Chemother,1999,43:48-52.
6Granizo JJ,Aguilar L,Casal J,et al.Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).J Antimicrob Chemother,2000,46:767-773.
7Nishijima T,Saito Y,Aoki A,et al.Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics.J Antimicrob Chemother,1999,43:637-643.
8Brantl S,Kummer C,Behnke D.Complete nucleotide sequence of plasmid pGB3631, a derivative of the Streptococcus agalactiae plasmid pIP501[].Gene.1994
9Joyce S,Thorsten G,Amelia TK,et al.Detection of erythromycinresistant determinants by PCR[].Antimicrobial Agents and Chemotherapy.1996
10Marilyn CR,Joyce S,Patrice C,et al.Nomenclature for macrolidelincosamide-streptogramin B resistance determinants[].Antimicrobial Agents and Chemotherapy.1999
